Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US
Associate Director, Global Production Planning & Inventory Control Job
Celgene Corporation - Basking Ridge, NJ, US
Partner
Lundbeckfond Ventures - Copenhagen, Denmark
Analyst, Procurement Operations Job
Celgene Corporation - Basking Ridge, NJ, US

More Jobs >>

Events

Partnerships in Clinical Trials 2012
March 4-7 — Orlando, FL
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Just Released: New Trends in Preventive and Therapeutic Vaccine
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia

More Events >>

Related Tags >> FDA BLA adenovirus Vaccine

Barr Pharmaceuticals News

Most Popular Barr Pharmaceuticals Story

FDA accepts Barr BLA for first biologics

December 11, 2008 — 5:28pm ET | By Calisha Myers

Barr Pharmaceuticals announced Thursday that the FDA has accepted their application for the company's first two biologics, developed for the Department of Defense. The vaccine pills are designed to Read more...

Barr Pharmaceuticals Press Releases

Barr Laboratories, Inc. issues a voluntary nationwide recall of Dextroamphetamine/Amphetamine 20mg Tablets, Lot number 311756
Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
Teva Draws on $1.75 Billion Bridge Financing in Connection with Pending Barr Acquisition
Barr Shareholders Approve Pending Teva Acquisition
Teva Announces Agreement on Allegra Patent Challenge

Latest Headlines

FDA accepts Barr BLA for first biologics
December 11, 2008

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK